News

With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.
Weight loss drugs like Wegovy and Zepbound are getting cheaper, if you are willing to pay out of pocket for the medications.
Whichever way the tariff winds blow (and I've no special knowledge of that), Novo Nordisk stock remains arguably the cheapest ...
Walmart is trying to hold the line. You're listening to Motley Fool Money. I'm Ricky Mulvey. Joined today over the Internet ...